Ald-Ph-NHS ester structure
|
Common Name | Ald-Ph-NHS ester | ||
|---|---|---|---|---|
| CAS Number | 60444-78-2 | Molecular Weight | 247.204 | |
| Density | 1.4±0.1 g/cm3 | Boiling Point | 425.4±47.0 °C at 760 mmHg | |
| Molecular Formula | C12H9NO5 | Melting Point | 163ºC | |
| MSDS | Chinese USA | Flash Point | 211.1±29.3 °C | |
Use of Ald-Ph-NHS esterAld-Ph-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC). |
| Name | N-Succinimidyl p-Formylbenzoate |
|---|---|
| Synonym | More Synonyms |
| Description | Ald-Ph-NHS ester is a nonclaevable linker for antibody-drug-conjugation (ADC). |
|---|---|
| Related Catalog | |
| Target |
Noncleavable |
| Density | 1.4±0.1 g/cm3 |
|---|---|
| Boiling Point | 425.4±47.0 °C at 760 mmHg |
| Melting Point | 163ºC |
| Molecular Formula | C12H9NO5 |
| Molecular Weight | 247.204 |
| Flash Point | 211.1±29.3 °C |
| Exact Mass | 247.048065 |
| PSA | 80.75000 |
| LogP | -0.20 |
| Vapour Pressure | 0.0±1.0 mmHg at 25°C |
| Index of Refraction | 1.606 |
| Storage condition | -20°C |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| RIDADR | NONH for all modes of transport |
| HS Code | 2925190090 |
|
~99%
Ald-Ph-NHS ester CAS#:60444-78-2 |
| Literature: Quinton, Julia; Kolodych, Sergii; Chaumonet, Manon; Bevilacqua, Valentina; Nevers, Marie-Claire; Volland, Herve; Gabillet, Sandra; Thuery, Pierre; Creminon, Christophe; Taran, Frederic Angewandte Chemie - International Edition, 2012 , vol. 51, # 25 p. 6144 - 6148 |
|
~%
Ald-Ph-NHS ester CAS#:60444-78-2 |
| Literature: Organic and Biomolecular Chemistry, , vol. 8, # 19 p. 4329 - 4345 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2925190090 |
|---|---|
| Summary | 2925190090 other imides and their derivatives; salts thereof VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:30.0% |
|
PSMA-specific theranostic nanoplex for combination of TRAIL gene and 5-FC prodrug therapy of prostate cancer.
Biomaterials 80 , 57-67, (2016) Metastatic prostate cancer causes significant morbidity and mortality and there is a critical unmet need for effective treatments. We have developed a theranostic nanoplex platform for combined imagin... |
|
|
A strategy for the systematic development of a liquid chromatographic mass spectrometric screening method for polymer electrolyte membrane degradation products using isocratic and gradient phase optimized liquid chromatography.
J. Chromatogr. A. 1216 , 8910-8917, (2009) Within the scope of research for target and non-target LC-MS/MS analysis of membrane degradation products of polymer electrolyte membrane fuel cells, a systematic method development for the separation... |
|
|
Synthesis of pH-sensitive amphotericin B-poly(ethylene glycol) conjugates and study of their controlled release in vitro.
Bioorg. Med. Chem. 15 , 4069-4076, (2007) New intravenous conjugates of amphotericin B (AMB) with poly(ethylene glycols) (PEG) (M=5000, 10,000, 20,000) have been synthesized and characterised. The intermediate PEGs possess a 1,4-disubstituted... |
| Benzaldehyde, 4-[[(2,5-dioxo-1-pyrrolidinyl)oxy]carbonyl]- |
| (2,5-dioxopyrrolidin-1-yl) 4-formylbenzoate |
| 4-{[(2,5-Dioxo-1-pyrrolidinyl)oxy]carbonyl}benzaldehyde |